NCT05086120

Brief Summary

This is a one-armed observational study and feasibility trial of a remote electronically-delivered integrated care pathway for the treatment of adolescents. Eligible participants are between the ages of 13 and 18, inclusive, who have a primary diagnosis of major depressive disorder. Outcomes of interest are recruitment rates and participation in pathway components, including: appointments, measure-completion and use of electronically-delivered cognitive behavioural therapy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable major-depressive-disorder

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable major-depressive-disorder

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 20, 2021

Completed
1.2 years until next milestone

Study Start

First participant enrolled

January 4, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 23, 2024

Completed
Last Updated

March 6, 2024

Status Verified

March 1, 2024

Enrollment Period

1.1 years

First QC Date

October 8, 2021

Last Update Submit

March 5, 2024

Conditions

Keywords

Tele-psychiatryAdolescentDepressionMeasurement Based CareCognitive Behaviour Therapye-mental health

Outcome Measures

Primary Outcomes (8)

  • Recruitment

    Time it takes to recruit 12 participants to the study

    6 months

  • Number of Psychiatry Appointments

    Proportion of scheduled psychiatry appointments attended (number attended divided by 4 for each participant)

    16 weeks

  • Number of iCBT Content Viewed

    Proportion of online CBT videos viewed per participant (number viewed divided by 54)

    16 weeks

  • Number of Health Coach Text Messages

    Number of text messages the participant sent to the health coach (count data)

    16 weeks

  • Fitbit Usage

    Number of days the fitbit is worn and the percentage of data collected

    16 weeks

  • Psychiatric Management

    Number of events involving of self-harm behaviour/suicidal ideation that required acute psychiatric management (where the study psychiatrist needs to communicate with the youth and/or family members outside of regular appointments every 4 weeks).

    16 weeks

  • Youth's Experience with eCARIBOU

    Qualitative Interview feedback from youth pertaining to the intervention - including ease of use, content relevance, level of engagement with the intervention

    16 weeks

  • ICP Deviations

    Frequency of deviations from the pathway and any documented reasons for deviations

    16 weeks

Study Arms (1)

Remote Electronically Delivered Integrated Care Pathway (ICP)

EXPERIMENTAL

The remote electronically-delivered ICP (also known as eCARIBOU) will consist of psychiatry appointments through telemedicine every 4 weeks over 16 weeks, where the youth is at home. Prior to these appointments, measures (i.e., Mood and Feelings Questionnaire - MFQ) will be sent to the youth to be completed. Change in measure scores will be reviewed collaboratively between the psychiatrist and the youth to assist in making treatment decisions. The medication algorithm in the in-person ICP will be used to guide these decisions. The psychiatrist will also administer the Columbia Suicide Severity Rating Scale (C-SSRS) at each telepsychiatry appointment to monitor risk. Concurrently, youth will be offered internet-based Cognitive Behavioural Therapy (iCBT) and health-coaching via text.

Other: eCARIBOU

Interventions

A 16 week remote electronically deliver Integrated Care Pathway (ICP) for adolescents (13-18 years old) with Major Depressive Disorder (MDD).

Remote Electronically Delivered Integrated Care Pathway (ICP)

Eligibility Criteria

Age13 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • years old at baseline
  • Mood and Feelings Questionnaire - Childhood, long version (MFQ) score of ≥22
  • Diagnosis of Major Depressive Disorder by impression from the referring psychiatrist and confirmed using the KSADS
  • Internet access at home
  • Access to a smartphone for personal and private use, with an associated standard data plan (ie. greater than or equal to 500 MB/month)
  • Able to speak and read English fluently

You may not qualify if:

  • Individuals that arecurrently receiving structured psychotherapy
  • Clinically significant suicidal ideation that is defined as 'imminent intent' or attempted suicide in the past 6 months
  • Co-morbid diagnosis of borderline personality disorder (as assessed by the Childhood Interview for Borderline Personality Disorder) (Zanarini, 2003), schizophrenia, bipolar disorder, moderate-to-severe eating disorder, obsessive compulsive disorder and/or severe alcohol/substance use disorder in the past 3 months
  • Youth with known or clinically suspected intellectual disability or autism spectrum disorder
  • Youth who are not able to provide informed consent for any other reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

The Center for Addiction and Mental Health

Toronto, Ontario, M6J 1H4, Canada

Location

Centre for Addiction and Mental Health

Toronto, Ontario, Canada

Location

Related Publications (1)

  • Ritvo P, Knyahnytska Y, Pirbaglou M, Wang W, Tomlinson G, Zhao H, Linklater R, Bai S, Kirk M, Katz J, Harber L, Daskalakis Z. Online Mindfulness-Based Cognitive Behavioral Therapy Intervention for Youth With Major Depressive Disorders: Randomized Controlled Trial. J Med Internet Res. 2021 Mar 10;23(3):e24380. doi: 10.2196/24380.

    PMID: 33688840BACKGROUND

MeSH Terms

Conditions

Depressive Disorder, MajorDepression

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Darren Courtney, MD

    Centre for Addiction and Mental Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Adolescents (age 13-18) with major depressive disorder.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinician Scientist with the Cundill Centre for Child and Youth Depression and a Staff Psychiatrist in the Youth Addictions and Concurrent Disorders Service

Study Record Dates

First Submitted

October 8, 2021

First Posted

October 20, 2021

Study Start

January 4, 2023

Primary Completion

January 23, 2024

Study Completion

January 23, 2024

Last Updated

March 6, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations